4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000008
Chief Scientific Officer sold 51,707 shares at an average $28.40 ($1,468,251)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lillie James Woodruff Chief Scientific Officer | 2026-05-04 | Sale 10b5-1 | −9,250 | $27.50 | $254,375 | 285,907 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-04 | Sale 10b5-1 | −5,526 | $28.37 | $156,773 | 280,381 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-04 | Sale 10b5-1 | −320 | $29.56 | $9,459 | 280,061 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-04 | Sale 10b5-1 | −705 | $30.08 | $21,206 | 279,356 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-05 | Sale 10b5-1 | −10,132 | $28.12 | $284,912 | 269,224 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-05 | Sale 10b5-1 | −963 | $29.00 | $27,927 | 268,261 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-06 | Sale 10b5-1 | −8,390 | $28.04 | $235,256 | 259,871 | D |
| Lillie James Woodruff Chief Scientific Officer | 2026-05-06 | Sale 10b5-1 | −16,421 | $29.13 | $478,344 | 243,450 | D |
| Open-market sales · 51,707 sh · avg $28.40 · $1,468,251 | |||||||
Loading xslF345X06/form4-05062026_080505.xml…